TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,953 | -16.3% | 213,223 | +36.8% | 0.00% | – |
| Q2 2023 | $45,345 | -84.6% | 155,826 | 0.0% | 0.00% | – |
| Q1 2023 | $294,511 | +126844.4% | 155,826 | 0.0% | 0.00% | – |
| Q4 2022 | $232 | -99.9% | 155,826 | -0.2% | 0.00% | – |
| Q3 2022 | $260,000 | -16.7% | 156,158 | 0.0% | 0.00% | – |
| Q2 2022 | $312,000 | -22.4% | 156,158 | +2.0% | 0.00% | – |
| Q1 2022 | $402,000 | +1.0% | 153,060 | +6.4% | 0.00% | – |
| Q4 2021 | $398,000 | -29.4% | 143,912 | -1.3% | 0.00% | – |
| Q3 2021 | $564,000 | -36.9% | 145,745 | +5.7% | 0.00% | – |
| Q2 2021 | $894,000 | +3.6% | 137,822 | +31.3% | 0.00% | – |
| Q1 2021 | $863,000 | +7.5% | 104,954 | +52.8% | 0.00% | – |
| Q4 2020 | $803,000 | – | 68,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
| Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
| Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
| Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
| X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
| NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |